BioIntelliSense has enabled medical-grade Remote Patient Monitoring Hospital at Home (RPM-H@H) via its BioSticker-based data service. The BioStickerâ„¢ is an FDA-cleared 510k class II wearable medical device that enables at-home continuous monitoring of vital signs and symptoms directly associated with COVID-19 (temperature, respiratory rate at rest, and coughing frequency) for 30 days on a single device without recharging.
|
|
|
51-200 employees
View all BioIntelliSense, Inc employees
|
|
Medical Device
|
|
Denver, Colorado , US
|
|
None
|
James Mault is the CEO of BioIntelliSense, Inc. To contact James Mault email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.